A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Sweden- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Sweden248 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)
Sweden
Sweden
Sweden
Sweden
Sweden
Sweden
Sweden
Sweden
Sweden
Sweden
Sweden
SwedenThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.
Innovative research comparing various treatment protocols and investigating survival outcomes.
Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.
Focus on prevention and immune response in various age groups.
Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.
Emphasis on improving patient outcomes and testing novel drug combinations.
Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.
Studies evaluating both novel and existing therapeutic approaches.
Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.
Focus on lifestyle interventions combined with pharmaceutical approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.